Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study.
Am J Transplant
; 20(1): 159-171, 2020 01.
Article
en En
| MEDLINE
| ID: mdl-31509331
Palabras clave
clinical research/practice; immunosuppressant -fusion proteins and monoclonal antibodies; immunosuppressant-antiproliferative agent: mycophenolate mofetil; immunosuppressant-calcineurin inhibitor: tacrolimus; immunosuppression/immune modulation; kidney transplantation/nephrology; kidney transplantation: living donor; translational research/science
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Complicaciones Posoperatorias
/
Trasplante de Riñón
/
Anticuerpos Monoclonales Humanizados
/
Rechazo de Injerto
/
Supervivencia de Injerto
/
Inmunosupresores
/
Fallo Renal Crónico
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Transplant
Asunto de la revista:
TRANSPLANTE
Año:
2020
Tipo del documento:
Article